Virax Biolabs Group Ltd (VRAX) is a in vitro & in vivo diagnostic substances company incorporated in Cayman Islands, listed on the Nasdaq. With a market capitalization of $2 million, Virax Biolabs Group Ltd is a micro-cap company. The stock currently trades at $0.22, down 4.92% today, with a 52-week range of $0.20–$1.85.
No 10-K filings found.